{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:20:16Z","timestamp":1791465616256,"version":"4.3.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation of Beijing Municipality,China","award":["82073215"],"award-info":[{"award-number":["82073215"]}]},{"name":"Natural Science Foundation of Beijing Municipality,China","award":["7222001"],"award-info":[{"award-number":["7222001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-02726-1","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T06:56:59Z","timestamp":1770965819000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["ZNF638 represses the transcription of HBV closed circular DNA involving HUSH complex-mediated histone modifications of epigenetic silencing"],"prefix":"10.1186","volume":"24","author":[{"given":"Sifan","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binwei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"issue":"10381","key":"2726_CR1","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/S0140-6736(22)01468-4","volume":"401","author":"WJ Jeng","year":"2023","unstructured":"Jeng WJ, Papatheodoridis GV, Lok A, Hepatitis B. Lancet. 2023;401(10381):1039\u201352.","journal-title":"Lancet"},{"issue":"8","key":"2726_CR2","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1080\/14787210.2023.2225771","volume":"21","author":"C Forbes","year":"2023","unstructured":"Forbes C, Lavoie L, Satram S, Shen L, Thanawala V, Arizpe A, et al. Global importance of new treatment strategies to efforts to control hepatitis B virus. Expert Rev Anti Infect Ther. 2023;21(8):847\u201362.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2726_CR3","doi-asserted-by":"publisher","first-page":"m2200","DOI":"10.1136\/bmj.m2200","volume":"370","author":"Y Shi","year":"2020","unstructured":"Shi Y, Zheng M. Hepatitis B virus persistence and reactivation. BMJ. 2020;370:m2200.","journal-title":"BMJ"},{"issue":"9","key":"2726_CR4","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.molmed.2022.06.002","volume":"28","author":"L Mak","year":"2022","unstructured":"Mak L, Cheung K, Fung J, Seto W, Yuen M. New strategies for the treatment of chronic hepatitis B. Trends Mol Med. 2022;28(9):742\u201357.","journal-title":"Trends Mol Med"},{"issue":"Suppl","key":"2726_CR5","doi-asserted-by":"publisher","first-page":"S134","DOI":"10.3350\/cmh.2024.0780","volume":"31","author":"D Wu","year":"2025","unstructured":"Wu D, Kao J, Piratvisuth T, Wang X, Kennedy PTF, Otsuka M, et al. Update on the treatment navigation for functional cure of chronic hepatitis B: expert consensus 2.0. Clin Mol Hepatol. 2025;31(Suppl):S134\u201364.","journal-title":"Clin Mol Hepatol"},{"issue":"12","key":"2726_CR6","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","volume":"64","author":"M Nassal","year":"2015","unstructured":"Nassal M. HBV cccdna: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B. Gut. 2015;64(12):1972\u201384.","journal-title":"Gut"},{"issue":"1 Suppl","key":"2726_CR7","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.jhep.2016.01.027","volume":"64","author":"S Tong","year":"2016","unstructured":"Tong S, Revill P. Overview of hepatitis B viral replication and genetic variability. J Hepatol. 2016;64(1 Suppl):S4\u201316.","journal-title":"J Hepatol"},{"issue":"1","key":"2726_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1053\/j.gastro.2014.04.030","volume":"147","author":"S Urban","year":"2014","unstructured":"Urban S, Bartenschlager R, Kubitz R, Zoulim F. Strategies to inhibit entry of HBV and HDV into hepatocytes. Gastroenterology. 2014;147(1):48\u201364.","journal-title":"Gastroenterology"},{"issue":"4","key":"2726_CR9","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.tim.2018.01.009","volume":"26","author":"C Shih","year":"2018","unstructured":"Shih C, Yang CC, Choijilsuren G, Chang CH, Liou AT, Hepatitis B, Virus. Trends Microbiol. 2018;26(4):386\u20137.","journal-title":"Trends Microbiol"},{"key":"2726_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-981-13-9151-4_2","volume":"1179","author":"J Wang","year":"2020","unstructured":"Wang J, Huang H, Liu Y, Chen R, Yan Y, Shi S, et al. HBV genome and life cycle. Adv Exp Med Biol. 2020;1179:17\u201337.","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"2726_CR11","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.3390\/cells9092023","volume":"9","author":"B Jiang","year":"2020","unstructured":"Jiang B, Hildt E. Intracellular trafficking of HBV particles. Cells. 2020;9(9):2023\u201344.","journal-title":"Cells"},{"key":"2726_CR12","doi-asserted-by":"publisher","first-page":"104925","DOI":"10.1016\/j.antiviral.2020.104925","volume":"182","author":"S Tsukuda","year":"2020","unstructured":"Tsukuda S, Watashi K. Hepatitis B virus biology and life cycle. Antiviral Res. 2020;182:104925\u201335.","journal-title":"Antiviral Res"},{"key":"2726_CR13","doi-asserted-by":"publisher","first-page":"1349867","DOI":"10.3389\/fimmu.2024.1349867","volume":"15","author":"Z Wang","year":"2024","unstructured":"Wang Z, Liu N, Yang Y, Tu Z. The novel mechanism facilitating chronic hepatitis B infection: immunometabolism and epigenetic modification reprogramming. Front Immunol. 2024;15:1349867\u201381.","journal-title":"Front Immunol"},{"issue":"4","key":"2726_CR14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.tig.2022.12.005","volume":"39","author":"M Seczynska","year":"2023","unstructured":"Seczynska M, Lehner PJ. The sound of silence: mechanisms and implications of HUSH complex function. Trends Genet. 2023;39(4):251\u201367.","journal-title":"Trends Genet"},{"issue":"6242","key":"2726_CR15","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1126\/science.aaa7227","volume":"348","author":"IA Tchasovnikarova","year":"2015","unstructured":"Tchasovnikarova IA, Timms RT, Matheson NJ, Wals K, Antrobus R, Gottgens B, et al. GENE SILENCING. Epigenetic Silencing by the HUSH complex mediates position-effect variegation in human cells. Science. 2015;348(6242):1481\u20135.","journal-title":"Science"},{"issue":"1","key":"2726_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12977-022-00610-7","volume":"19","author":"V Vauthier","year":"2022","unstructured":"Vauthier V, Lasserre A, Morel M, Versapuech M, Berlioz-Torrent C, Zamborlini A, et al. HUSH-mediated HIV Silencing is independent of TASOR phosphorylation on threonine 819. Retrovirology. 2022;19(1):23\u201335.","journal-title":"Retrovirology"},{"issue":"7","key":"2726_CR17","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/ng.3878","volume":"49","author":"IA Tchasovnikarova","year":"2017","unstructured":"Tchasovnikarova IA, Timms RT, Douse CH, Roberts RC, Dougan G, Kingston RE, et al. Hyperactivation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2. Nat Genet. 2017;49(7):1035\u201344.","journal-title":"Nat Genet"},{"issue":"1","key":"2726_CR18","doi-asserted-by":"publisher","first-page":"5387","DOI":"10.1038\/s41467-020-19170-5","volume":"11","author":"H Tunbak","year":"2020","unstructured":"Tunbak H, Enriquez-Gasca R, Tie C, Gould PA, Mlcochova P, Gupta RK, et al. The HUSH complex is a gatekeeper of type I interferon through epigenetic regulation of LINE-1s. Nat Commun. 2020;11(1):5387\u201397.","journal-title":"Nat Commun"},{"issue":"6","key":"2726_CR19","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3390\/v12060596","volume":"12","author":"K Fukuda","year":"2020","unstructured":"Fukuda K, Shinkai Y. SETDB1-Mediated Silencing of retroelements. Viruses. 2020;12(6):596\u2013613.","journal-title":"Viruses"},{"issue":"7893","key":"2726_CR20","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/s41586-021-04228-1","volume":"601","author":"M Seczynska","year":"2022","unstructured":"Seczynska M, Bloor S, Cuesta SM, Lehner PJ. Genome surveillance by HUSH-mediated Silencing of intronless mobile elements. Nature. 2022;601(7893):440\u20135.","journal-title":"Nature"},{"issue":"4","key":"2726_CR21","doi-asserted-by":"publisher","first-page":"e0203921","DOI":"10.1128\/jvi.02039-21","volume":"96","author":"A Das","year":"2022","unstructured":"Das A, Vijayan M, Walton EM, Stafford VG, Fiflis DN, Asokan A. Epigenetic Silencing of Recombinant Adeno-associated virus genomes by NP220 and the HUSH complex. J Virol. 2022;96(4):e0203921.","journal-title":"J Virol"},{"issue":"7735","key":"2726_CR22","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41586-018-0750-6","volume":"564","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Wang GZ, Cingoz O, Goff SP. NP220 mediates Silencing of unintegrated retroviral DNA. Nature. 2018;564(7735):278\u201382.","journal-title":"Nature"},{"issue":"8","key":"2726_CR23","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.3390\/v13081463","volume":"13","author":"L Wei","year":"2021","unstructured":"Wei L, Ploss A. Mechanism of hepatitis B virus CccDNA formation. Viruses. 2021;13(8):1463\u201373.","journal-title":"Viruses"},{"issue":"14","key":"2726_CR24","doi-asserted-by":"publisher","first-page":"8045","DOI":"10.1128\/JVI.01024-14","volume":"88","author":"Z Qi","year":"2014","unstructured":"Qi Z, Li G, Hu H, Yang C, Zhang X, Leng Q, et al. Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice. J Virol. 2014;88(14):8045\u201356.","journal-title":"J Virol"},{"key":"2726_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-1-4939-6700-1_2","volume":"1540","author":"Y Ni","year":"2017","unstructured":"Ni Y, Urban S, Hepatitis B. Virus infection of HepaRG Cells, HepaRG-hNTCP Cells, and primary human hepatocytes. Methods Mol Biol. 2017;1540:15\u201325.","journal-title":"Methods Mol Biol"},{"key":"2726_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-6700-1_1","volume":"1540","author":"Y Sun","year":"2017","unstructured":"Sun Y, Qi Y, Peng B, Li W. NTCP-Reconstituted in vitro HBV infection system. Methods Mol Biol. 2017;1540:1\u201314.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"2726_CR27","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1038\/s41467-018-05096-6","volume":"9","author":"RA Wesselhoeft","year":"2018","unstructured":"Wesselhoeft RA, Kowalski PS, Anderson DG. Engineering circular RNA for potent and stable translation in eukaryotic cells. Nat Commun. 2018;9(1):2629\u201339.","journal-title":"Nat Commun"},{"issue":"9","key":"2726_CR28","doi-asserted-by":"publisher","first-page":"e02036","DOI":"10.1128\/JVI.02036-18","volume":"93","author":"T Flecken","year":"2019","unstructured":"Flecken T, Meier MA, Skewes-Cox P, Barkan DT, Heim MH, Wieland SF, et al. Mapping the heterogeneity of histone modifications on hepatitis B virus DNA using liver needle biopsies obtained from chronically infected patients. J Virol. 2019;93(9):e02036\u201318.","journal-title":"J Virol"},{"issue":"24","key":"2726_CR29","doi-asserted-by":"publisher","first-page":"7345","DOI":"10.7150\/thno.37173","volume":"9","author":"G Yang","year":"2019","unstructured":"Yang G, Feng J, Liu Y, Zhao M, Yuan Y, Yuan H, et al. HAT1 signaling confers to assembly and epigenetic regulation of HBV CccDNA minichromosome. Theranostics. 2019;9(24):7345\u201358.","journal-title":"Theranostics"},{"issue":"2","key":"2726_CR30","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s13337-013-0155-y","volume":"24","author":"H Changotra","year":"2013","unstructured":"Changotra H, Sehajpal PK. An improved method for the isolation of hepatitis B virus DNA from human serum. Indian J Virol. 2013;24(2):174\u20139.","journal-title":"Indian J Virol"},{"issue":"2","key":"2726_CR31","doi-asserted-by":"publisher","first-page":"e0136021","DOI":"10.1128\/JVI.01360-21","volume":"96","author":"AL Marchetti","year":"2022","unstructured":"Marchetti AL, Zhang H, Kim ES, Yu X, Jang S, Wang M, et al. Proteomic analysis of nuclear hepatitis B virus relaxed circular DNA-Associated proteins identifies UV-Damaged DNA binding protein as a host factor involved in covalently closed circular DNA formation. J Virol. 2022;96(2):e0136021.","journal-title":"J Virol"},{"issue":"7","key":"2726_CR32","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1038\/s41596-018-0063-0","volume":"14","author":"J Joung","year":"2019","unstructured":"Joung J, Konermann S, Gootenberg JS, Abudayyeh OO, Platt RJ, Brigham MD, et al. Author correction: Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening. Nat Protoc. 2019;14(7):2259\u201371.","journal-title":"Nat Protoc"},{"issue":"5","key":"2726_CR33","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41564-020-0678-0","volume":"5","author":"L Wei","year":"2020","unstructured":"Wei L, Ploss A. Core components of DNA lagging strand synthesis machinery are essential for hepatitis B virus CccDNA formation. Nat Microbiol. 2020;5(5):715\u201326.","journal-title":"Nat Microbiol"},{"key":"2726_CR34","doi-asserted-by":"publisher","first-page":"105552","DOI":"10.1016\/j.antiviral.2023.105552","volume":"211","author":"X Yu","year":"2023","unstructured":"Yu X, Long Q, Shen S, Liu Z, Chandran J, Zhang J, et al. Screening of an epigenetic compound library identifies BRD4 as a potential antiviral target for hepatitis B virus covalently closed circular DNA transcription. Antiviral Res. 2023;211:105552\u201363.","journal-title":"Antiviral Res"},{"key":"2726_CR35","doi-asserted-by":"publisher","first-page":"100261","DOI":"10.1016\/j.aohep.2020.09.005","volume":"21","author":"F Alvarez-Astudillo","year":"2021","unstructured":"Alvarez-Astudillo F, Garrido D, Varas-Godoy M, Gutierrez JL, Villanueva RA, Loyola A. The histone variant H3.3 regulates the transcription of the hepatitis B virus. Ann Hepatol. 2021;21:100261\u201363.","journal-title":"Ann Hepatol"},{"issue":"5","key":"2726_CR36","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jhep.2015.06.023","volume":"63","author":"L Riviere","year":"2015","unstructured":"Riviere L, Gerossier L, Ducroux A, Dion S, Deng Q, Michel ML, et al. HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral CccDNA involving SETDB1 histone methyltransferase. J Hepatol. 2015;63(5):1093\u2013102.","journal-title":"J Hepatol"},{"issue":"2","key":"2726_CR37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00281-020-00780-6","volume":"42","author":"M Dandri","year":"2020","unstructured":"Dandri M. Epigenetic modulation in chronic hepatitis B virus infection. Semin Immunopathol. 2020;42(2):173\u201385.","journal-title":"Semin Immunopathol"},{"issue":"21","key":"2726_CR38","doi-asserted-by":"publisher","first-page":"12525","DOI":"10.1074\/jbc.271.21.12525","volume":"271","author":"H Inagaki","year":"1996","unstructured":"Inagaki H, Matsushima Y, Nakamura K, Ohshima M, Kadowaki T, Kitagawa Y. A large DNA-binding nuclear protein with RNA recognition motif and serine\/arginine-rich domain. J Biol Chem. 1996;271(21):12525\u201331.","journal-title":"J Biol Chem"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-02726-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02726-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02726-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:18:35Z","timestamp":1774019915000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-02726-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2726"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-02726-1","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Serum samples utilized in the study were collected within protocols approved by the Ethics Committee of Beijing You\u2019an Hospital, with the approval number 7222096.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"186"}}